scholarly article | Q13442814 |
P356 | DOI | 10.1517/14728222.2015.1072513 |
P698 | PubMed publication ID | 26220265 |
P50 | author | Kaido Kurrikoff | Q44567523 |
Ülo Langel | Q47087785 | ||
P2093 | author name string | Krista Freimann | |
P2860 | cites work | Intraventricular galanin modulates a 5-HT1A receptor-mediated behavioural response in the rat. | Q48388908 |
Galanin-5-hydroxytryptamine interactions: electrophysiological, immunohistochemical and in situ hybridization studies on rat dorsal raphe neurons with a note on galanin R1 and R2 receptors | Q48403369 | ||
Restricted distribution of galanin receptor 3 (GalR3) mRNA in the adult rat central nervous system | Q48457696 | ||
Characterization and localization of galanin receptors in human entorhinal cortex | Q48485114 | ||
Galanin receptor over-expression within the amygdala in early Alzheimer's disease: an in vitro autoradiographic analysis | Q48504105 | ||
Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities | Q48864164 | ||
Role of galanin receptor 1 and galanin receptor 2 activation in synaptic plasticity associated with 3',5'-cyclic AMP response element-binding protein phosphorylation in the dentate gyrus: studies with a galanin receptor 2 agonist and galanin recepto | Q48891603 | ||
Distribution of galaninergic immunoreactivity in the brain of the mouse | Q48893571 | ||
Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease | Q48967823 | ||
Intraventricular galanin produces a time-dependent modulation of 5-HT1A receptors in the dorsal raphe of the rat. | Q49012883 | ||
Localization of preprogalanin messenger RNA in rat brain: identification of transcripts in a subpopulation of cerebellar Purkinje cells | Q49123493 | ||
Effect of intrathecal galanin and its putative antagonist M35 on pain behavior in a neuropathic pain model | Q49149270 | ||
Constitutive and ligand-induced internalization of EGFP-tagged galanin R2 and Rl receptors in PC12 cells | Q50766587 | ||
Galanin neurons in the intermediate nucleus (InM) of the human hypothalamus in relation to sex, age, and gender identity | Q51458133 | ||
Galanin impairs acquisition but not retrieval of spatial memory in rats studied in the Morris swim maze | Q52123291 | ||
Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression | Q53187673 | ||
Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3 | Q22008499 | ||
Molecular cloning of a functional human galanin receptor | Q24306226 | ||
Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels | Q24309179 | ||
Molecular characterization, pharmacological properties and chromosomal localization of the human GALR2 galanin receptor | Q24319129 | ||
Galanin pathogenic mutations in temporal lobe epilepsy | Q24319705 | ||
Anticonvulsant activity of a nonpeptide galanin receptor agonist | Q24531395 | ||
Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice | Q24537325 | ||
Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299. | Q24537645 | ||
Synthesis of galmic: a nonpeptide galanin receptor agonist | Q24559130 | ||
Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests | Q24564195 | ||
Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective? | Q24601893 | ||
Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests | Q24630830 | ||
Genome-wide atlas of gene expression in the adult mouse brain | Q26253934 | ||
A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclinical tests | Q28252871 | ||
Critical role for GALR1 galanin receptor in galanin regulation of neuroendocrine function and seizure activity | Q48269162 | ||
Galanin: a significant role in depression? | Q48294893 | ||
Galanin inhibits performance on rodent memory tasks | Q48294914 | ||
Galanin modulates 5-hydroxytryptamine functions. Focus on galanin and galanin fragment/5-hydroxytryptamine1A receptor interactions in the brain | Q48294936 | ||
Galanin reduces release of endogeneous excitatory amino acids in the rat hippocampus | Q48320065 | ||
Galanin receptor antagonists M40 and C7 block galanin-induced feeding | Q48346724 | ||
Structural organization of the mouse and human GALR1 galanin receptor genes (Galnr and GALNR) and chromosomal localization of the mouse gene | Q28254468 | ||
Differential role of galanin receptors in the regulation of depression-like behavior and monoamine/stress-related genes at the cell body level | Q28263350 | ||
Galanin and its receptors in neurological disorders | Q28264297 | ||
Galanin attenuates beta-amyloid (Abeta) toxicity in rat cholinergic basal forebrain neurons | Q28278813 | ||
Galanin and epilepsy | Q28281285 | ||
Genomic organization and localization of the gene encoding human preprogalanin | Q28285645 | ||
Cloning and characterization of the human galanin GALR2 receptor | Q28293104 | ||
Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities | Q28302683 | ||
The brain galanin receptors: targets for novel antidepressant drugs | Q28303033 | ||
Novel galanin receptor subtype specific ligands in feeding regulation | Q28305689 | ||
The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease | Q28307983 | ||
Expression Cloning of a Rat Hypothalamic Galanin Receptor Coupled to Phosphoinositide Turnover | Q28572322 | ||
Visualization of a functionally enhanced GFP-tagged galanin R2 receptor in PC12 cells: constitutive and ligand-induced internalization | Q28575154 | ||
Differential Intracellular Signaling of the GalR1 and GalR2 Galanin Receptor Subtypes | Q28582628 | ||
Binding of Chimeric Peptides M617 and M871 to Galanin Receptor Type 3 Reveals Characteristics of Galanin Receptor–Ligand Interaction | Q29040426 | ||
Phenotypic analysis of mice deficient in the type 2 galanin receptor (GALR2). | Q30475920 | ||
Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice | Q30532216 | ||
Effects of centrally administered galanin (1-16) on galanin expression in the rat hypothalamus | Q30968681 | ||
Galanin hyperinnervation upregulates choline acetyltransferase expression in cholinergic basal forebrain neurons in Alzheimer's disease. | Q33678393 | ||
Colocalization of galanin and luteinizing hormone-releasing hormone in a subset of preoptic hypothalamic neurons: anatomical and functional correlates | Q33750501 | ||
The role of galanin in feeding behavior | Q33829084 | ||
Galanin fiber hyperinnervation preserves neuroprotective gene expression in cholinergic basal forebrain neurons in Alzheimer's disease. | Q33908982 | ||
Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: selective actions via GalR1 and GalR2 receptors | Q33934812 | ||
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models | Q34093567 | ||
Cloning and characterization of a novel G-protein-coupled receptor with homology to galanin receptors | Q34316713 | ||
Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studies | Q34356002 | ||
Galanin/GALP and galanin receptors: role in central control of feeding, body weight/obesity and reproduction? | Q34635512 | ||
Construction of a porcine adrenal medullary cDNA library and nucleotide sequence analysis of two clones encoding a galanin precursor | Q35054541 | ||
Differential activity by polymorphic variants of a remote enhancer that supports galanin expression in the hypothalamus and amygdala: implications for obesity, depression and alcoholism | Q35222822 | ||
Galanin and galanin receptors in epilepsy | Q35965246 | ||
Galanin receptor ligands | Q36156070 | ||
Galanin and spinal nociceptive mechanisms: recent results from transgenic and knock-out models | Q36156098 | ||
Galanin receptors and ligands | Q36451712 | ||
Postendocytotic traffic of the galanin R1 receptor: a lysosomal signal motif on the cytoplasmic terminus | Q36535543 | ||
Galanin impairs cognitive abilities in rodents: relevance to Alzheimer's disease | Q37171921 | ||
A role for galanin in human and experimental inflammatory demyelination | Q37320724 | ||
Galanin acts as a neuroprotective factor to the hippocampus | Q37416301 | ||
Impairment of memory consolidation by galanin correlates with in vivo inhibition of both LTP and CREB phosphorylation | Q37436783 | ||
Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease | Q37546301 | ||
Galanin stimulates neurite outgrowth from sensory neurons by inhibition of Cdc42 and Rho GTPases and activation of cofilin | Q37604336 | ||
M-15: high-affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus coeruleus, and spinal cord | Q37638977 | ||
Physiology, signaling, and pharmacology of galanin peptides and receptors: three decades of emerging diversity | Q38271920 | ||
cDNA sequence, ligand biding, and regulation of galanin/GMAP in mouse brain | Q38289093 | ||
Distribution of galanin messenger RNA-expressing cells in murine brain and their regulation by leptin in regions of the hypothalamus | Q38303344 | ||
Galanin-R1 and -R2 receptor mRNA expression during the development of rat brain suggests differential subtype involvement in synaptic transmission and plasticity | Q38308638 | ||
Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrus | Q38339673 | ||
Galanin (2-11) binds to GalR3 in transfected cell lines: limitations for pharmacological definition of receptor subtypes | Q40412251 | ||
Regulation of anterior pituitary galanin gene expression by thyroid hormone. | Q41071863 | ||
The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans | Q41148169 | ||
Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. | Q41255070 | ||
Characterization of the 5'-flanking region of the human preprogalanin gene | Q41357210 | ||
On the existence and function of galanin receptor heteromers in the central nervous system | Q41889343 | ||
Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer's disease. | Q42489299 | ||
Distribution of galanin-like immunoreactivity in the human brain | Q42490902 | ||
Activation of the galanin receptor 2 (GalR2) protects the hippocampus from neuronal damage | Q42507592 | ||
Galanin/GMAP- and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and -R2 receptors | Q42544280 | ||
Behavioural characterisation of young adult transgenic mice overexpressing galanin under the PDGF-B promoter | Q42642053 | ||
Galanin: stimulation of feeding induced by medial hypothalamic injection of this novel peptide | Q43437739 | ||
2,3-Dihydro-dithiin and -dithiepine-1,1,4,4-tetroxides: small molecule non-peptide antagonists of the human galanin hGAL-1 receptor | Q43505099 | ||
Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease | Q44045750 | ||
Immunohistochemical mapping of galanin-like neurons in the rat central nervous system | Q44097639 | ||
Exogenous galanin attenuates spatial memory impairment and decreases hippocampal β-amyloid levels in rat model of Alzheimer's disease | Q44260000 | ||
Evidence for a role of the neuropeptide galanin in spatial learning | Q44332862 | ||
Anticonvulsive effects of galanin administered into the central nervous system upon the picrotoxin-kindled seizure syndrome in rats | Q44399336 | ||
Altered hippocampal expression of neuropeptides in seizure-prone GALR1 knockout mice | Q44530091 | ||
Microarray analysis of postictal transcriptional regulation of neuropeptides | Q46412841 | ||
Homodimerization and internalization of galanin type 1 receptor in living CHO cells | Q46768490 | ||
Galanin receptor-1 knockout mice exhibit spontaneous epilepsy, abnormal EEGs and altered inhibition in the hippocampus | Q46769076 | ||
Isolation and cDNA cloning of a novel galanin-like peptide (GALP) from porcine hypothalamus | Q47900449 | ||
Evidence for Hydrophobic Interaction between Galanin and the GalR1 Galanin Receptor and GalR1-Mediated Ligand Internalization: Fluorescent Probing with a Fluorescein−Galanin | Q47900849 | ||
NGF and LIF both regulate galanin gene expression in primary DRG cultures | Q47959103 | ||
Cloning and expressional characterization of a novel galanin receptor. Identification of different pharmacophores within galanin for the three galanin receptor subtypes | Q48040979 | ||
Molecular cloning and characterisation of the mouse preprogalanin gene | Q48056889 | ||
Galanin selectively modulates 5-hydroxytryptamine 1A receptors in the rat ventral limbic cortex | Q48112060 | ||
Intracerebroventricular administration of galanin or galanin receptor subtype 1 agonist M617 induces c-Fos activation in central amygdala and dorsomedial hypothalamus. | Q48253532 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1665-1676 | |
P577 | publication date | 2015-07-28 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | Expert Opinion on Therapeutic Targets | Q5421214 |
P1476 | title | Galanin receptors as a potential target for neurological disease | |
P478 | volume | 19 |
Q41139465 | An analysis of possible off target effects following CAS9/CRISPR targeted deletions of neuropeptide gene enhancers from the mouse genome |
Q38935590 | Challenges for the in vivo quantification of brain neuropeptides using microdialysis sampling and LC-MS. |
Q38766134 | Dataset on Galanin Receptor 3 mutants that improve recombinant receptor expression and stability in an agonist and antagonist bound form |
Q41120997 | Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer |
Q88213463 | Neuronal hypothalamic regulation of body metabolism and bone density is galanin dependent |
Q60938770 | Neuropeptide and Small Transmitter Coexistence: Fundamental Studies and Relevance to Mental Illness |
Q47961085 | Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis |
Q47597808 | Trends in GPCR drug discovery: new agents, targets and indications. |
Q37681012 | Zinc in the Monoaminergic Theory of Depression: Its Relationship to Neural Plasticity. |